학술논문
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Document Type
Article
Author
Tao, Y.; Ruffier, A.; Biau, J.; Miroir, J.; Chautard, E.; Sun, X.S.; Sire, C.; Martin, L.; Alfonsi, M.; Prevost, J.B.; Modesto, A.; Lafond, C.; Tourani, J.M.; Kaminsky, M.C.; Coutte, A.; Liem, X.; Vauleon, E.; Drouet, F.; Ramee, J.F.; Waksi, G.; Péchery, A.; Wanneveich, M.; Guigay, J.; Aupérin, A.; Bourhis, J.
Source
In: Annals of Oncology . (Annals of Oncology, January 2023, 34(1):101-110)
Subject
Language
English
ISSN
15698041
09237534
09237534